PL3075724T3 - Stała postać agomelatyny - Google Patents

Stała postać agomelatyny

Info

Publication number
PL3075724T3
PL3075724T3 PL15162055.6T PL15162055T PL3075724T3 PL 3075724 T3 PL3075724 T3 PL 3075724T3 PL 15162055 T PL15162055 T PL 15162055T PL 3075724 T3 PL3075724 T3 PL 3075724T3
Authority
PL
Poland
Prior art keywords
agomelatine
solid form
solid
Prior art date
Application number
PL15162055.6T
Other languages
English (en)
Inventor
Gregory Bydlinski
Alessandro Gagnoni
Antonio Germani
Original Assignee
F.I.S.- Fabbrica Italiana Sintetici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.I.S.- Fabbrica Italiana Sintetici S.P.A. filed Critical F.I.S.- Fabbrica Italiana Sintetici S.P.A.
Publication of PL3075724T3 publication Critical patent/PL3075724T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15162055.6T 2015-03-31 2015-03-31 Stała postać agomelatyny PL3075724T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15162055.6A EP3075724B1 (en) 2015-03-31 2015-03-31 Solid form of agomelatine

Publications (1)

Publication Number Publication Date
PL3075724T3 true PL3075724T3 (pl) 2023-12-27

Family

ID=52811020

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15162055.6T PL3075724T3 (pl) 2015-03-31 2015-03-31 Stała postać agomelatyny

Country Status (5)

Country Link
EP (1) EP3075724B1 (pl)
CN (1) CN107074743B (pl)
ES (1) ES2959460T3 (pl)
PL (1) PL3075724T3 (pl)
WO (1) WO2016156089A1 (pl)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866335B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2889522B1 (fr) 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889521B1 (fr) 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889523B1 (fr) 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2923482B1 (fr) 2007-11-09 2010-01-29 Servier Lab Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
CN101585779B (zh) 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
WO2011006387A1 (zh) 2009-07-11 2011-01-20 浙江华海药业股份有限公司 阿戈美拉汀的制备方法、阿戈美拉汀晶形及其制备方法
CN101955440B (zh) 2009-07-17 2014-04-09 江苏万特制药有限公司 一种阿戈美拉汀新晶型及其制备方法
CN102001959B (zh) 2009-09-01 2014-07-02 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
WO2012046253A2 (en) 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
CN102030673B (zh) 2010-11-24 2014-04-23 威海迪素制药有限公司 一种阿戈美拉汀新晶型及制备方法
WO2012093402A1 (en) 2011-01-04 2012-07-12 Symed Labs Limited Processes for the preparation of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
CN102690209A (zh) 2011-03-23 2012-09-26 上海医药工业研究院 阿戈美拉汀的混晶(形式-ⅷ)、其制备方法、应用和包含其的药物组合物
CN102690210A (zh) 2011-03-23 2012-09-26 上海医药工业研究院 阿戈美拉汀的新晶型ⅶ、其制备方法、应用和包含其的药物组合物
WO2012130837A1 (en) 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
EP2517700B1 (en) 2011-04-28 2013-07-17 Zentiva, k.s. Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation
PH12012000132B1 (en) 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2976284B1 (fr) * 2011-06-09 2013-05-24 Servier Lab Nouveaux co-cristaux d'agomelatine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CN102702008B (zh) * 2012-06-03 2014-05-28 上海右手医药科技开发有限公司 阿戈美拉汀硫酸复合物及其制备方法
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法

Also Published As

Publication number Publication date
EP3075724B1 (en) 2023-07-12
CN107074743B (zh) 2019-05-14
CN107074743A (zh) 2017-08-18
ES2959460T3 (es) 2024-02-26
EP3075724A1 (en) 2016-10-05
WO2016156089A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
IL287437A (en) Flavociclib solid dosage forms
IL257026A (en) Solid state forms of eluxadoline
HUE044083T2 (hu) Alvivõk újracstornázása
PL3059223T3 (pl) Wytwarzanie mieszanin estrów
GB201501583D0 (en) Uses of co-crystals
IL254089A0 (en) Desacetoxytobulizin h and its analogs
IL269409A (en) Combinations of chk1- and wee1 - inhibitors
SI3154526T1 (sl) Trdne oblike sofosbuvira
PT3474822T (pt) Formulações de brincidofovir
IL274627A (en) Solid forms of valbenazine
IL265628A (en) Solid state forms of valbenazine
ZA201706282B (en) Solid forms of menaquinols
IL246979A0 (en) Crystalline forms of sofosbuvir
GB201504934D0 (en) Improved method of FT-IMS
HRP20190403T1 (hr) Postupak izrade lakozamida
IL272670A (en) Preparation of micro-electrodes
IL265180B (en) New polymorphs and new solid states of tiacomycin b
IL255819A (en) An improved process for the preparation of sofosbuvir and intermediates
IL249130B (en) Preparation of piperidine-4-carbothioamide
IL254666A0 (en) Crystalline forms of Aldecalcitol
PL3075724T3 (pl) Stała postać agomelatyny
GB201721386D0 (en) Chrondogy of time-wave
IL249332A0 (en) Crystalline forms of sofosbuvir
PT3377478T (pt) Co-cristais de bilastina
GB201502834D0 (en) Composition of objects